nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

por Gajra, Ajeet, Karim, Nagla Abdel, Mulford, Deborah A., Villaruz, Liza Cosca, Matrana, Marc Ryan, Ali, Haythem Y., Santos, Edgardo S., Berry, Tymara, Ong, Teng Jin, Sanford, Alexandra, Amiri, Katayoun, Spigel, David R.
Publicado 2018